Search
for
Sort by
Research 211–240 of 580
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Alopecia areata – Aktuelles Verständnis und Management
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Baricitinib: A Review in Severe Alopecia Areata
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- New Modalities in the Treatment of Refractory Alopecia Areata
- Vitiligo—Current Treatment Options and Future Perspectives
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Exploring novel management options for alopecia areata
- Stem cell-based therapies for alopecia areata: a narrative review
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Real-world evidence in alopecia areata treatment: A narrative review
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- The Frontal Fibrosing Alopecia Treatment Dilemma